Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
MabVax Therapeutics Holdings, Inc. (MBVXQ) had Debt to Capital Ratio of 0.95 for the most recently reported fiscal quarter, ending 2018-09-30.
| Income Statement Financials | |
$4.00M |
|
$0.34M |
|
$0.79M |
|
$3.21M |
|
$3.51M |
|
$0.49M |
|
$-0.15M |
|
$0.34M |
|
$0.34M |
|
$0.34M |
|
$0.34M |
|
$0.34M |
|
$0.34M |
|
$0.49M |
|
$0.63M |
|
9.25M |
|
17.12M |
|
$0.04 |
|
$0.02 |
|
| Balance Sheet Financials | |
$1.44M |
|
$0.46M |
|
$7.46M |
|
$8.90M |
|
$7.77M |
|
$0.84M |
|
$1.09M |
|
$8.85M |
|
$0.03M |
|
$-6.78M |
|
$0.04M |
|
9.26M |
|
| Cash Flow Statement Financials | |
$-2.62M |
|
-- |
|
$2.69M |
|
$0.89M |
|
$0.95M |
|
$0.07M |
|
$1.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.18 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.95 |
63.10 |
|
80.38% |
|
12.37% |
|
12.37% |
|
-- |
|
8.52% |
|
8.52% |
|
$-2.62M |
|
-- |
|
-- |
|
-- |
|
0.45 |
|
-- |
|
-- |
|
-- |
|
1001.43% |
|
-5.02% |
|
3.83% |
|
38.40% |
|
$0.00 |
|
$-0.15 |
|
$-0.15 |
|